Literature DB >> 9072548

Urine autoantibodies in interstitial cystitis.

S Keay1, C O Zhang, A L Trifillis, J R Hebel, S C Jacobs, J W Warren.   

Abstract

Interstitial cystitis is a chronic bladder disease with certain features that suggest autoimmunity may play a role in initiating or maintaining the disease process. We therefore determined whether immunoglobulin fractions from 14 IC patient and 19 control urine specimens bound in vitro to primary cultures of human bladder epithelial cells, as well as epithelial cells from a variety of other tissues. Urine autoantibodies that bound to normal human bladder epithelial cells were present in 8 of 14 IC specimens (from 6 of 9 IC patients) as compared to 3 of 23 control specimens (from 2 of 17 control patients). These antibodies, which were usually also present at low titers in sera from these persons, bound to at least four nuclear or cytoplasmic antigens, with the specificity of autoantibodies from a given individual varying over time. The autoantibodies were not specific for normal or malignant bladder epithelial cells, but bound to epithelial cells from a variety of tissues. These data show that anti-epithelial cell autoantibodies are present in the urine of IC patients, but suggest that these antibodies are not likely to be a primary cause of this disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9072548

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Interstitial cystitis: characterization and management of an enigmatic urologic syndrome.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2002

2.  Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats.

Authors:  Tsuyoshi Majima; Yasuhito Funahashi; Shun Takai; William F Goins; Momokazu Gotoh; Pradeep Tyagi; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2015-08-31       Impact factor: 5.695

Review 3.  Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis.

Authors:  Ioannis Mykoniatis; Stavros Tsiakaras; Michael Samarinas; Anastasios Anastasiadis; Evangelos N Symeonidis; Petros Sountoulides
Journal:  Biologics       Date:  2022-05-20

Review 4.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

5.  RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model.

Authors:  Wujiang Liu; Barry R Deyoung; Xiaohong Chen; David P Evanoff; Yi Luo
Journal:  J Autoimmun       Date:  2007-12-26       Impact factor: 7.094

6.  Autoimmunity to urothelial antigen causes bladder inflammation, pelvic pain, and voiding dysfunction: a novel animal model for Hunner-type interstitial cystitis.

Authors:  Yoshiyuki Akiyama; Jian-Rong Yao; Karl J Kreder; Michael A O'Donnell; Susan K Lutgendorf; Dan Lyu; Daichi Maeda; Haruki Kume; Yukio Homma; Yi Luo
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-14

7.  Comparison of 5 Different Rat Models to Establish a Standard Animal Model for Research Into Interstitial Cystitis.

Authors:  Phil Hyun Song; So Young Chun; Jae-Wook Chung; Yeon Yong Kim; Hyo Jung Lee; Jun Nyung Lee; Yun-Sok Ha; Eun Sang Yoo; Tae Gyun Kwon; Jeongshik Kim; Dae Hwan Kim; Bum Soo Kim
Journal:  Int Neurourol J       Date:  2017-09-12       Impact factor: 2.835

8.  Identification of novel biomarkers in Hunner's interstitial cystitis using the CIBERSORT, an algorithm based on machine learning.

Authors:  Kaining Lu; Shan Wei; Zhengyi Wang; Kerong Wu; Junhui Jiang; Zejun Yan; Yue Cheng
Journal:  BMC Urol       Date:  2021-08-16       Impact factor: 2.264

9.  Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice.

Authors:  Kenan Izgi; Cengiz Z Altuntas; Fuat Bicer; Ahmet Ozer; Cagri Sakalar; Xiaoxia Li; Vincent K Tuohy; Firouz Daneshgari
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

10.  Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.

Authors:  Marianne Gamper; Volker Viereck; Jakob Eberhard; Jochen Binder; Carlo Moll; Joellen Welter; René Moser
Journal:  Int Urogynecol J       Date:  2013-05-14       Impact factor: 2.894

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.